Abstract
Retinal neovascularization is a major cause of blindness and requires the activities of several signaling pathways and multiple cytokines. Activation of protein kinase C (PKC) enhances the angiogenic process and is involved in the signaling of vascular endothelial growth factor (VEGF). We have demonstrated a dramatic increase in the angiogenic response to oxygen-induced retinal ischemia in transgenic mice overexpressing PKCβ2 isoform and a significant decrease in retinal neovascularization in PKCβ isoform null mice. The mitogenic action of VEGF, a potent hypoxia-induced angiogenic factor, was increased by 2-fold in retinal endothelial cells by the overexpression of PKCβ1 or β2 isoforms and inhibited significantly by the overexpression of a dominant-negative PKCβ2 isoform but not by the expression of PKC α, δ, and ζ isoforms. Association of PKCβ2 isoform with retinoblastoma protein was discovered in retinal endothelial cells, and PKCβ2 isoform increased retinoblastoma phosphorylation under basal and VEGF-stimulated conditions. The potential functional consequences of PKCβ-induced retinoblastoma phosphorylation could include enhanced E2 promoter binding factor transcriptional activity and increased VEGF-induced endothelial cell proliferation.
Bibliography
Suzuma, K., Takahara, N., Suzuma, I., Isshiki, K., Ueki, K., Leitges, M., Aiello, L. P., & King, G. L. (2002). Characterization of protein kinase C β isoformâs action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. Proceedings of the National Academy of Sciences, 99(2), 721â726.
References
32
Referenced
140
10.1074/jbc.275.7.5096
10.1172/JCI119006
10.1038/sj.onc.1202527
10.1038/362841a0
10.1038/359845a0
10.1172/JCI5929
10.2337/diab.46.9.1473
10.1056/NEJM199412013312203
10.1172/JCI117784
10.1172/JCI4394
10.1073/pnas.94.17.9320
10.1126/science.273.5276.788
10.1073/pnas.92.23.10457
- L E Smith, E Wesolowski, A McLellan, S K Kostyk, R D'Amato, R Sullivan, P A D'Amore Invest Ophthalmol Visual Sci 35, 101–111 (1994). / Invest Ophthalmol Visual Sci by Smith L E (1994)
10.2337/diab.45.8.1016
10.1172/JCI5971
10.1172/JCI111764
10.1074/jbc.272.7.4072
10.1016/S0021-9258(18)47044-5
10.1074/jbc.270.14.8311
10.1083/jcb.144.3.413
10.1073/pnas.95.5.2509
10.2337/diab.44.1.98
10.1073/pnas.92.13.5855
- T Sakamoto, T Ishibashi, H Kimura, H Yoshikawa, C Spee, M S Harris, D R Hinton, S J Ryan Invest Ophthalmol Visual Sci 36, 1076–1083 (1995). / Invest Ophthalmol Visual Sci by Sakamoto T (1995)
10.1126/science.272.5262.728
10.1002/(SICI)1521-1878(199911)21:11<950::AID-BIES7>3.0.CO;2-D
10.1016/S0021-9258(18)68471-6
10.1091/mbc.8.2.287
10.1074/jbc.272.19.12738
10.1128/MCB.19.5.3246
10.1128/MCB.17.10.5771
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 10:36 a.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 9:02 a.m.) |
Indexed | 1 week, 3 days ago (Aug. 26, 2025, 2:29 a.m.) |
Issued | 23 years, 7 months ago (Jan. 22, 2002) |
Published | 23 years, 7 months ago (Jan. 22, 2002) |
Published Online | 23 years, 7 months ago (Jan. 22, 2002) |
Published Print | 23 years, 7 months ago (Jan. 22, 2002) |
@article{Suzuma_2002, title={Characterization of protein kinase C β isoform’s action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization}, volume={99}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.022644499}, DOI={10.1073/pnas.022644499}, number={2}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Suzuma, Kiyoshi and Takahara, Noriko and Suzuma, Izumi and Isshiki, Keiji and Ueki, Kohjiro and Leitges, Michael and Aiello, Lloyd Paul and King, George L.}, year={2002}, month=jan, pages={721–726} }